Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Increasing antimicrobial resistance poses a significant global health threat.
• Streptococcus pneumoniae is a common cause of bacterial infections, with rising resistance rates.
• Understanding the drivers of antimicrobial resistance is crucial for effective treatment strategies.

Purpose of the Study:

• To examine the association between outpatient antimicrobial drug use and the susceptibility patterns of Streptococcus pneumoniae.
• To identify potential links between specific antibiotic classes and reduced susceptibility in clinical isolates.

Main Methods:

• Data on outpatient antimicrobial drug consumption were collected for regions surrounding 23 U.S. medical centers.
• Susceptibility data for Streptococcus pneumoniae isolates from 24 U.S. medical centers were analyzed.
• Statistical analysis was performed to correlate antimicrobial use with antimicrobial susceptibility.

Main Results:

• A significant association was observed between the use of beta-lactam antimicrobial drugs and decreased penicillin susceptibility in Streptococcus pneumoniae.
• Regional antimicrobial drug use patterns were linked to changes in bacterial susceptibility.
• The findings highlight a direct relationship between antibiotic exposure and resistance development.

Conclusions:

• The use of beta-lactam antimicrobial drugs is associated with reduced susceptibility of Streptococcus pneumoniae to penicillin.
• This study underscores the importance of antimicrobial stewardship to mitigate the rise of drug-resistant bacteria.
• Further research is warranted to explore broader antimicrobial classes and resistance mechanisms.